Corrigendum to 'Activation of GPER suppresses migration and angiogenesis of triple negative breast cancer via inhibition of NF-κB/IL-6 signals' [Cancer Lett. 386 (2017) 12–23]
0301 basic medicine Cancer Research biology Angiogenesis business.industry Cancer NF-κB medicine.disease 03 medical and health sciences chemistry.chemical_compound 030104 developmental biology 0302 clinical medicine Oncology chemistry 030220 oncology & carcinogenesis Immunology Cancer research biology.protein Medicine business Interleukin 6 GPER Triple-negative breast cancer